Vyxeos for Induction of Low- or Intermediate-risk.

Clinical trial NCT05599360 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05599360
Sponsor: Shaare Zedek Medical Center
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Leukemia, Myeloid, Acute

Start date: 2022-08-07
Primary completion: 2028-09-07
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.